Brind.

Goldman Sachs amassed bullish positions on Viking Therapeutics.

1 report, 0 independent Updated Jul 4

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Goldman Sachs Viking Therapeutics

Keep exploring

The entities involved

Goldman Sachs
American investment bank
- BXP purchased a building in Manhattan with Goldman Sachs, which is now occupied by Weil Gotshal.00:47
- Multiple financial institutions, including Goldman Sachs, Morgan Stanley, Bank of America, UBS, and others, provided ratings and price targets for Marvell Technology on May 28, 2026.Fri 22:25
Viking Therapeutics
company in San Diego, United States

Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped

Jul 4Unknown outlet